The recent decision by the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate Depo-Provera lawsuits into ...

2025年3月12日，新泽西州马尔顿——越来越多使用Depo-Provera（注射用醋酸美托洛尔）避孕的女性因新研究结果而表示健康担忧，该研究显示该药与脑膜瘤风险增加相关。多名长期使用此类孕激素注射的女性报告出现慢性头痛、视力问题、头晕、记忆障碍及癫痫等神经系统症状，这些症状通常与脑肿瘤相关。

A federal judge appointed Christopher Seeger of Seeger Weiss LLP lead counsel for the plaintiffs in consolidated litigation ...

Depo-Provera, a widely used injectable type of contraceptive, has played a significant role in reproductive healthcare for many years as it offers countless women a convenient and low-maintenance ...

Depo-Provera is an injectable form of birth control. Bleeding and changes to menstrual flow are common during the first year of use. However, bleeding after using Depo-Provera typically resolves ...

Singleton Schreiber says the lawsuits filed involve the Depo-Provera injectable birth control injection made by Pfizer. The firm says the injection has been linked to an increased risk of ...

Depo-Provera has been linked to brain tumors, neurological damage, and vision loss. Lawsuits claim Pfizer failed to warn users of these risks.

MARLTON, N.J., March 12, 2025 /PRNewswire/ -- A growing number of women who received Depo-Provera injections are coming forward with serious health concerns following new research linking the ...